The advantages of GLP-1 agonists include substantial clinical trial data supporting their efficacy and safety, FDA approval for weight management in certain populations, proven results with many users losing 15-20% or more of body weight, and effects on appetite that make caloric restriction feel natural
BPC-157 Pathways BPC-157 promotes angiogenesis via VEGF upregulation, modulates the nitric oxide system for optimal tissue perfusion, enhances expression of growth factors (FGF, EGF, TGF-), and exhibits potent anti-inflammatory activity through cytokine modulation
BPC-157 performs best when the problem is biologically suited to tissue repair: tendon irritation, ligament sprain, muscle strain, fascia irritation, or gut mucosal inflammation
Using ineffective peptide wastes time more than money